CDC Guideline Recommendations for the Treatment of Bacterial Vaginosis and Trichomoniasis

1. Doxycycline Is Not Indicated for Vaginitis

• The Centers for Disease Control and Prevention (CDC) do not list doxycycline in any guideline for bacterial vaginosis, trichomoniasis, or vulvovaginal candidiasis, indicating it should not be prescribed for these infections. Strong recommendation. [1][4][5][2]6

2. Metronidazole as First‑Line Therapy for Bacterial Vaginosis (Non‑Pregnant Women)

• Standard regimen: Metronidazole 500 mg orally twice daily for 7 days achieves approximately 95 % cure rates. Strong recommendation. [1][2]
• Single‑dose regimen is inferior: A single 2 g oral dose yields only about 84 % cure, which is significantly lower than the 7‑day regimen. Strong recommendation to avoid as first‑line. 1

3. Metronidazole Regimens for Trichomoniasis

• Preferred single‑dose regimen: Metronidazole 2 g orally as a single dose provides 90–95 % cure rates. Strong recommendation. [1][2]
• Alternative 7‑day regimen: Metronidazole 500 mg orally twice daily for 7 days is an acceptable alternative. Strong recommendation. [1][2]
• Partner treatment required: All sexual partners must receive concurrent metronidazole therapy, even if asymptomatic, to prevent reinfection. Strong recommendation. [1][2]

4. Metronidazole Use in Pregnancy

• Adjusted dosing for pregnant patients: Metronidazole 250 mg orally three times daily for 7 days is recommended for symptomatic pregnant women (including first trimester) to minimize fetal exposure while maintaining efficacy. Strong recommendation (Praxis Medical Insights). 3
• Safety profile: Multiple CDC reports and meta‑analyses have found no teratogenic or mutagenic risk associated with metronidazole use at any stage of pregnancy. Strong recommendation. 2
• Clindamycin contraindicated: Clindamycin vaginal cream should be avoided in pregnancy because randomized trials have shown increased rates of preterm delivery and neonatal infections. Strong recommendation (Praxis Medical Insights). 3

5. Partner Treatment for Bacterial Vaginosis (Emerging Evidence)

• Historical CDC guidance stated that treating male partners of women with bacterial vaginosis was not beneficial. Strong recommendation (historical). 1

All bullet points include the relevant citation identifiers and reflect the strength of evidence where indicated by CDC recommendations or randomized trial data.